Drug-device combination products: Regulatory landscape and market growth

Drugs of Today

Volumn 51, Issue 8, 2015, Pages 505-513

  Bayarri, L ^a  

^a THOMSON REUTERS   (United Kingdom)

Author keywords

Combination product; Drug device combination; Medical device; Regulatory

Indexed keywords

BIOLOGICAL PRODUCT; CETUXIMAB; DABRAFENIB; EVEROLIMUS; OLAPARIB; PACLITAXEL; TRASTUZUMAB; ZOTAROLIMUS;

CHINA; CLINICAL EFFECTIVENESS; DEVICE APPROVAL; DIABETES MELLITUS; DRUG APPROVAL; DRUG DELIVERY DEVICE; DRUG ELUTING STENT; DRUG MARKETING; DRUG TARGETING; EUROPEAN UNION; FOOD AND DRUG ADMINISTRATION; HEART DISEASE; HUMAN; INFUSION PUMP; JAPAN; MEDICAL DEVICE REGULATION; MULTIPLE SCLEROSIS; NEOPLASM; PERSONALIZED MEDICINE; PRODUCT DEVELOPMENT; PROFESSIONAL COMPETENCE; REVIEW; MARKETING; STANDARDS; UNITED STATES;

DEVICE APPROVAL; DRUG APPROVAL; DRUG-ELUTING STENTS; HUMANS; MARKETING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84942599044     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2015.51.8.2376223     Document Type: Review

References (15)

1. U.S. Food and Drug Administration. About combination products. FDA Web site, October 20, 2009. http://www.fda.gov/CombinationProducts/AboutCombinationProducts/default.htm. Accessed August 14, 2015.
2. U.S. Food and Drug Administration. Combination product definition. FDA Web site, December 21, 2011. http://www.fda.gov/CombinationProducts/AboutCombinationProducts/ucm118332.htm. Accessed August 14, 2015.
3. Research and Markets: Drug device combination products market - global industry analysis, size, share, growth, trends & forecast, 2013-2019 [news release]. Research and Markets, January 3, 2014. http://www.businesswire.com/news/home/20140103005382/en/Research-Markets-#.VYPnryGqpBc. Accessed August 14, 2015.
4. Couto, D.S., Perez-Breva L., Saraiva P., Cooney, C.L. Lessons from innovation in drug-device combination products. Adv Drug Deliv Rev 2012, 64(1): 69-77.
5. Getz, M.C., Shand, W.B, Wong, O., Garret, D.M. Combination products: A 40 year regulatory evolution. NSF 2015. http://www.nsf.org/newsroom-pdf/hs-combination-products-whitepaper.pdf. Accessed August 14, 2015.
6. BSX initiates Fast Study: New generation bioabsorbable scaffolds may challenge DES. Medical Device Daily, July 23, 2015. http://www.medicaldevicedaily.com/servlet/com.accumedia.web.Dispatcher?next=mdd-article&forceid=90350. Accessed August 14, 2015.
7. Siddharth, N., Pethani T., Sheth N.R. A review on comparison of regulatory requirements to approved drug device combination products in Europe and USA. World J Pharmacy Pharmaceut Sci 2015, 3(6): 455-75.
8. U.S. Food and Drug Administration. Office of combination products. FDA Web Site, February 6, 2015. http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/OfficeofScienceandHealthCoordination/ucm2018184.htm. Accessed August 14, 2015.
9. European Commission. MEDDEV. 2.1/3 Rev 3: Borderline Products, Drug-Delivery Products and Medical Devices incorporating, as an integral part, an Ancillary Medicinal Substance or an Ancillary Human Blood Derivative - Guidelines Relating to the Application of the Council Directive 90/385/EEC on Active Implantable Medical Devices, the Council Directive 93/42/EEC on Medical Devices. European Commission Guideline, December 2009. http://ec.europa.eu/health/medical-devices/files/meddev/2-1-3-rev-3-12-2009-en.pdf. Accessed August 14, 2015.
10. Global drug device combination products market to grow at 7.9% CAGR between 2013 and 2019 [news release]. Transparency Market Research, January 13, 2015. http://globenewswire.com/newsrelease/2015/01/13/697006/10115353/en/Global-DrugDevice-Combination-Products-Market-to-Grow-at-7-9CAGR-between-2013-and-2019-Transparency-Market-Research.html. Accessed August 14, 2015.
11. Sall, B.S., Lassoff, P., Babbitt, B. Getting started with a combination product Part II: European Regulations. MDDI, April 1, 2003. http://www.mddionline.com/article/getting-started-combination-productpart-ii-european-regulations. Accessed August 14, 2015.
12. Drug Development and Delivery. Combination product technology to reach $31 billion; sector attracting massive developmental companies. Drug Development and Delivery, October 3, 2015. http://drug-dev.com/Main/Back-Issues/Combination-Product-Technology-to-Reach-31-Billion-878.aspx#sthash.99uL0VcH.dpuf. Accessed August 14, 2015.
13. U.S. Food and Drug Administration. Performance report to Congress. FDA 2013. http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/PerformanceReports/CombinationProducts/UCM439389.pdf. Accessed August 14, 2015.
14. U.S. Food and Drug Administration. Premarket approval (PMA). FDA Web site, August 19, 2014. http://www.fda.gov/medicaldevices/deviceregulatio-nandguidance/howtomarketyourdevice/premarketsub-missions/premarketapprovalpma/default.htm. Accessed August 14, 2015.
15. U.S. Food and Drug Administration. Premarket notification 510(k). FDA Web site, July 1, 2015. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/PremarketSubmissions/PremarketNotification510k/default.htm. Accessed August 14, 2015.